Why LifeStance Health Group (LFST) Is Up 5.5% After Profitable Quarter, Higher Guidance And New Buyback

Simply Wall St.08-18

In the second quarter of 2026, LifeStance Health Group, Inc. reported revenue of US$435.35 million and net income of US$23.61 million, turned around from a net loss a year earlier, and completed a US$...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2660452322?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957","is_english":true,"pubTime":"2026-08-18 13:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2660452322","market":"sg","top_or_hot":-1,"title":"Why LifeStance Health Group (LFST) Is Up 5.5% After Profitable Quarter, Higher Guidance And New Buyback","media":"Simply Wall St.","content":"<div>\n<p>In the second quarter of 2026, LifeStance Health Group, Inc. reported revenue of US$435.35 million and net income of US$23.61 million, turned around from a net loss a year earlier, and completed a US$...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-lfst/lifestance-health-group/news/why-lifestance-health-group-lfst-is-up-55-after-profitable-q\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why LifeStance Health Group (LFST) Is Up 5.5% After Profitable Quarter, Higher Guidance And New Buyback</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy LifeStance Health Group (LFST) Is Up 5.5% After Profitable Quarter, Higher Guidance And New Buyback\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-08-18 13:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nasdaq-lfst/lifestance-health-group/news/why-lifestance-health-group-lfst-is-up-55-after-profitable-q><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>In the second quarter of 2026, LifeStance Health Group, Inc. reported revenue of US$435.35 million and net income of US$23.61 million, turned around from a net loss a year earlier, and completed a US$...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-lfst/lifestance-health-group/news/why-lifestance-health-group-lfst-is-up-55-after-profitable-q\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"FMED","symbol_name":"Fidelity Disruptive Medicine ETF","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-lfst/lifestance-health-group/news/why-lifestance-health-group-lfst-is-up-55-after-profitable-q","article_id":"2660452322","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-lfst/lifestance-health-group/news/why-lifestance-health-group-lfst-is-up-55-after-profitable-q","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2660452322","pubTimestamp":1787030492,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"In the second quarter of 2026, LifeStance Health Group, Inc. reported revenue of US$435.35 million and net income of US$23.61 million, turned around from a net loss a year earlier, and completed a US$97.19 million share repurchase program under its February 2026 authorization while also announcing a new up to US$100 million buyback.\nThe company also raised its full-year 2026 revenue outlook to a range of US$1.69 billion to US$1.73 billion, signaling management’s confidence alongside this...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"FMED":"Fidelity Disruptive Medicine ETF","LFST":"LifeStance Health Group, Inc.","BK4539":"次新股","AIPO":"Defiance AI and Power Infrastructure ETF","BK4196":"保健护理服务","BK4535":"淡马锡持仓"},"translate_title":"为什么 LifeStance Health Group (LFST) 在盈利季度、更高的指导和新的回购后上涨 5.5%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LFST":1.5,"AIPO":0.61,"FMED":0.6},"content_text":"In the second quarter of 2026, LifeStance Health Group, Inc. reported revenue of US$435.35 million and net income of US$23.61 million, turned around from a net loss a year earlier, and completed a US$97.19 million share repurchase program under its February 2026 authorization while also announcing a new up to US$100 million buyback. The company also raised its full-year 2026 revenue outlook to a range of US$1.69 billion to US$1.73 billion, signaling management’s confidence alongside this swing to profitability and continued capital returns through share repurchases. We’ll now examine how LifeStance’s transition to profitability and higher full-year revenue guidance may reshape its investment narrative for investors. Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 28 best rare earth metal stocks of the very few that mine this essential strategic resource.AdvertisementLifeStance Health Group Investment Narrative RecapTo own LifeStance, you need to believe its outpatient mental health model can turn early profitability into durable earnings while managing intense competition and reimbursement pressure. The sharp move to net income in Q2 2026 and higher full year revenue guidance reinforce the near term catalyst around scaling profitable growth, but they do not remove the key risk that pricing and payer dynamics could still constrain margins if conditions become less favorable. The most directly relevant update is the new up to US$100 million share repurchase program, announced alongside Q2 earnings. Coming after completing a prior US$97.19 million buyback, this adds a capital return element to the story and may matter for investors focused on per share metrics, especially as LifeStance works to prove that its new profitability level can withstand ongoing competition, clinician cost pressures and technology investment needs. Yet, despite these improving numbers, the real risk investors should be aware of is how reimbursement pressure could still... Read the full narrative on LifeStance Health Group (it's free!)LifeStance Health Group's narrative projects $2.4 billion revenue and $146.1 million earnings by 2029. This requires 14.2% yearly revenue growth and a $95.5 million earnings increase from $50.6 million today.Uncover how LifeStance Health Group's forecasts yield a $12.90 fair value, a 3% upside to its current price.Exploring Other PerspectivesLFST 1-Year Stock Price Chart Before this news, the most pessimistic analysts expected revenue of about US$2.2 billion and earnings near US$131.5 million by 2029, highlighting how much more cautious they are about reimbursement risk and technology execution compared with the consensus view.Explore 3 other fair value estimates on LifeStance Health Group - why the stock might be worth as much as 22% more than the current price!Decide For YourselfDisagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.A great starting point for your LifeStance Health Group research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.Our free LifeStance Health Group research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate LifeStance Health Group's overall financial health at a glance.Looking For Alternative Opportunities?Our top stock finds are flying under the radar-for now. Get in early:We've uncovered the 10 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.Capitalize on the AI infrastructure supercycle with our selection of the 56 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.AI is about to change healthcare. These 40 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: AI Stock Screener & AlertsOur new AI Stock Screener scans the market every day to uncover opportunities.• Dividend Powerhouses (3%+ Yield)• Undervalued Small Caps with Insider Buying• High growth Tech and AI CompaniesOr build your own from over 50 metrics.Explore Now for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.49.0","shortVersion":"4.49.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2660452322","isCrawlerRequest":true}